Singular Health Group (ASX:SHG) received US Food and Drug Administration (FDA) 510(k) clearance for 3DICOM MD Cloud, the cloud-based platform of its FDA-cleared 3DICOM MD software, according to a Tuesday filing with the Australian bourse.

The platform has been cleared as a Class II Software as a Medical Device, allowing for marketing and clinical use of the platform in the US, the filing said.

Shares rose 6% in midday trade on Tuesday.